Home   |  Publications   |   Conferences    |  Join   |   Contact   | Sitemap  
Facebook    Twitter     Linkedin     RSS     Google+    BLOG    You Tube
 

Journal of Pharmacogenomics & Pharmacoproteomics


Open Access
 
ISSN: 2153-0645
 
 
 
HOME » PHARMACOGENOMICS-PHARMACOPROTEOMICS
French Language  |  English
 
 
 
 
 
In Association with
 

About the Journal

The Journal of Pharmacogenomics & Pharmacoproteomics publishes articles on new innovations in the field of personalized medicines. The original research articles or current reviews published under the journal deals with the influence of genetic variations on drug response in patients and viceversa. The journal aims to publish innovations in customized drug discovery using proteome technology. The journal provides an open access platform to publish latest advancements in the field of drug design, drug development and drug delivery.
 

Journal of Pharmacogenomics & Pharmacoproteomics is an open access and peer reviewed journal includes a wide range of field in its discipline to create a platform for the authors to make their valuable contributions towards the journal and the peer review process promises the publishing of quality, reliable and important articles for the readers and authors of scholarly, academic and scientific field. 

 
The Journal of Pharmacogenomics & Pharmacoproteomics welcomes new innovations including but not limited to the field of drug development, pharmacogenomics, pharmacoproteomics, new discoveries in genomic targets, various drug responses due to genetic polymorphisms, chemogenomics, personalized medicines, drug dosage formulations, drug safety and its efficacy.
  flyer image Impact Factor: 1.05 *
Index Copernicus Value: 4.76
 

Journal of Pharmacogenomics & Pharmacoproteomics uses Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Pharmacogenomics & Pharmacoproteomics or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

   
Submit manuscript at http://www.editorialmanager.com/omicsgroup/ or send as an email attachment to the Editorial Office at editor.jpp@omicsgroup.us  
   
2nd International Conference on Genomics & Pharmacogenomics during September 08-09, 2014 at Double Tree by Hilton Hotel-Brownestone-University Raleigh, NC, USA. Genomics-2014 is a remarkable event which brings together a unique and international mix of genome researchers, geneticists, molecular biologists, health-care industrialists, leading universities and research institutions making the conference a perfect platform to share experience, foster collaboration across industry and academia, and evaluate emerging technologies. 
   
Aims and Scope 
 
*Unofficial 2013 Impact Factor was established by dividing the number of articles published in 2011 and 2012 with the number of times they are cited in 2013 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2011 and 2012, and ‘Y’ is the number of times these articles were cited in indexed journals during 2013 than, impact factor = X/Y

 

 

Recently published articles

Why Single Pharmacogenomic Trials Should be Very Significant?

Clive E Bowman

 
Pharmacogenomics Study of Clopidogrel by RFLP based Genotyping of CYP2C19 in Cardiovascular Disease Patients in North-East Population of India

Prasanthi SV, Vinayak S Jamdade, Nityanand B Bolshette, Ranadeep Gogoi and Mangala Lahkar

 
A High-throughput Real-time PCR Approach to Pharmacogenomics Studies

Toinette Hartshorne, Ferrier Le, Jordan Lang, Harrison Leong, Kathleen Hayashibara, Dominique Dewolf and Elliot Shelton

 
Influence of SLCO1B1 and SLCO2B1 Polymorphisms on Tacrolimus Pharmacokinetics and Clinical Response

Camila Alves, Claudia R Felipe, Alvaro M Nishikawa, Patricia C Salgado, Cristina Fajardo, Helio T Silva Jr, Jose Osmar M Pestana, Denize Zetchaku, Glaucio Spinelli, Nagilla Oliveira, Mario Hiroyuki Hirata, Rosario DC Hirata and Alice C Rodrigues

 
APOE-TOMM40 in the Pharmacogenomics of Dementia

Ramón Cacabelos, Dmitry Goldgaber, Alexander Vostrov, Hideyuki Matsuki, Clara Torrellas, Dolores Corzo, Juan Carlos Carril and Allen D Roses

 
Cytochrome 2C19 Enzyme Polymorphism Frequency in Different Indigenous Ethnic Groups in Russian Federation: A Systematic Review

Karin Mirzaev, Dmitriy Sychev, Goar Arutyunyan, Alla Yugay and Denis Andreev

 
 
 
 
 
 
20082014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version